Company developing early cancer-detection tests to cut 20% of workforce
The 10-year-old company — part of a group of Bay Area companies that have raised billions of dollars over the past decade — recently netted $254 million to develop tests that can sniff out various cancers from a simple blood draw or "liquid biopsy.".....»»
Phoenix biotech company raises $36.6M for early lung cancer detection
VisionGate is a clinical stage oncology pharmaceutical and diagnostics company focused on the early detection and prevention of cancer......»»
South Jersey health care startup raises $3.5 million
A South Jersey life sciences company developing a blood test for the early detection of Alzheimer's and Parkinson's disease, when treatments are likely to be more effective, has raised $3.5 million in equity financing. The private stock sale was dis.....»»
This 30-year-old entrepreneur wants to detect cancer early — and his company just snared $160 million to do it
Before he was a teenager, Freenome's cofounder worked at Apple; now his early cancer detection company has lined up a crucial $160 million funding round from Google-backed units and other high-profile investors......»»
Chinese investors lead another monster round into this early cancer detection company
Looking to detect cancer early through a simple blood test, Grail Inc. raised a $300 million from several Chinese investors on top of $1.2 billion in two earlier rounds over the past two years. The Menlo Park company, which has been rumored to be plan.....»»
Chinese investors lead another monster round for Menlo Park early cancer detection unicorn
Looking to detect cancer early through a simple blood test, Grail Inc. scored $300 million in new funding from several Chinese investors on top of the $1.2 billion it raised over the past two years. The Menlo Park company, which was rumored to be .....»»
IPO Report: Guardant Health IPO: 5 things to know about the startup that wants to detect cancer early
The startup’s cancer tests help match patients with the right treatments. It also has even bigger ambitions: to use its tests to find cancer recurrences, and even for early detection of cancers......»»
Guardant Health IPO: Startup wants to detect cancer early
The startup’s cancer tests help match patients with the right treatments. It also has even bigger ambitions: to use its tests to find cancer recurrences, and even for early detection of cancers......»»
Cancer Researchers Hope New Breath Test Will Lead to Detection Breakthrough
British researchers are testing a device which hopes to diagnose multiple types of cancer at an early stage Breath tests that could detect cancer are a longstan.....»»
Can the nose point the way to early lung cancer detection? This Peninsula company"s Big Pharma deal aims to find out
A simple nasal swab to detect early-stage lung cancer — perhaps even before symptoms appear — landed a South San Francisco diagnostics company a potential $20 million deal with health care giant Johnson & Johnson. Although the deal gives Vera.....»»
Skin cancer: Myths, detection, treatment and prevention
Most of us at one time or another have experienced the painful redness, peeling and even blistering resulting from a sunburn, but there are also longer-term problems such as early aging of the skin (brown spots or wrinkles) and skin cancer. Accordin.....»»
California firm"s total RTP headcount could hit 700+ jobs, documents show
A California firm focused on early detection of cancer picked Research Triangle Park for a $100 million, 400-job project. But that may be just a portion of the overall investment......»»
FTC sues to block Illumina"s $7.1B purchase of Menlo Park-based Grail
The Federal Trade Commission on Tuesday moved to block Illumina's planned $7.1 billion purchase of cancer detection startup Grail Inc. The acquisition would weaken innovation in the development of tests that can detect multiple types of cancer .....»»
In the money Feb. 15: Nearly $153M in deals, plus a new $60M VC fund
Publicly traded companies developing tests and treatments for cancer led capital raises this past week, as 11 Austin-area companies in all reported securing about $152.7 million in deals. Additionally, a venture capital firm investing in heavy industries.....»»
Gaithersburg biotech NexImmune files for IPO
The company, which is developing cancer treatments, plans to trade on the Nasdaq Global Market......»»
Cancer research biotech ImmunSYS files for bankruptcy
The company is a clinical-stage biopharmaceutical firm focused on developing new cancer immunotherapy treatments......»»
Springs Window Fashions to close Patrician Window Coverings plant, lay off employees
The Patrician Window Coverings plant in Webster is slated to close early next year, and all of its employees will be laid off. Parent company Springs Window Fashions LLC informed the Texas Workforce Commission that closing the plant at 12556 Ol.....»»
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020
VANCOUVER and HOUSTON, May 7, 2020 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ:EPIX, TSXV:EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corpora.....»»
Boeing"s stock is rising 6% despite posting dismal earnings and cutting 10% of its workforce (BA)
Associated Press Shares of Boeing jumped more than 6% in early Wednesday trading after the company reported first quarter earnings amid the coronavirus pandemic. The airplane maker.....»»
Why This Late-Stage Kidney Cancer Study Could Be Huge
Exelixis stock jumped early on Monday after the company, in conjunction with Bristol-Myers Squibb, announced positive late-stage results from its kidney cancer study......»»
University developing AI detection of blood cancer
A university research team has been developing AI-based analysis of general blood data to screen out phlebotomy cases with high risks for blood cancer......»»